RPS6KA2 and breast cancer: The mechanisms by which RSK-3 and RSK-4 inhibit cell proliferation are still unknown, but studies on these isoforms reveal that they induce a G1-phase arrest, as well as apoptosis, when overexpressed in ovarian and breast cancer cells [66,67].